Hillsdale Investment Management Inc. trimmed its stake in shares of Semler Scientific, Inc. (NASDAQ:SMLR – Free Report) by 10.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,300 shares of the company’s stock after selling 500 shares during the period. Hillsdale Investment Management Inc. owned 0.06% of Semler Scientific worth $126,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also modified their holdings of SMLR. Acadian Asset Management LLC grew its position in shares of Semler Scientific by 68.2% in the first quarter. Acadian Asset Management LLC now owns 165,876 shares of the company’s stock valued at $4,843,000 after purchasing an additional 67,282 shares in the last quarter. Horizon Investment Services LLC lifted its holdings in Semler Scientific by 35.8% during the 1st quarter. Horizon Investment Services LLC now owns 8,352 shares of the company’s stock worth $244,000 after buying an additional 2,203 shares in the last quarter. LSV Asset Management raised its stake in shares of Semler Scientific by 58.0% in the first quarter. LSV Asset Management now owns 252,887 shares of the company’s stock valued at $7,387,000 after acquiring an additional 92,851 shares in the last quarter. Greenwood Capital Associates LLC raised its position in Semler Scientific by 38.1% in the 1st quarter. Greenwood Capital Associates LLC now owns 21,883 shares of the company’s stock valued at $639,000 after purchasing an additional 6,036 shares in the last quarter. Finally, Janney Montgomery Scott LLC acquired a new position in shares of Semler Scientific during the first quarter worth about $700,000. Hedge funds and other institutional investors own 49.37% of the company’s stock.
Semler Scientific Trading Up 2.1 %
SMLR stock traded up $0.72 during trading on Monday, hitting $34.25. 361,790 shares of the company’s stock were exchanged, compared to its average volume of 197,092. The stock has a market capitalization of $242.15 million, a price-to-earnings ratio of 12.28 and a beta of 1.01. Semler Scientific, Inc. has a 52-week low of $20.88 and a 52-week high of $53.38. The business has a 50-day moving average price of $31.77 and a two-hundred day moving average price of $34.85.
Analysts Set New Price Targets
Separately, Lake Street Capital upgraded shares of Semler Scientific to a “strong-buy” rating in a research note on Wednesday, May 8th.
View Our Latest Stock Report on Semler Scientific
Semler Scientific Profile
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Featured Articles
- Five stocks we like better than Semler Scientific
- Consumer Discretionary Stocks Explained
- Intuitive Surgical Stock Outperforms Market: Highs on the Horizon
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Has This Leading Tech Stock Halted the AI Surge?
- How to Invest in the FAANG Stocks
- Revolutionary Battery Stock Gains Momentum with 3D Silicon-Anodes
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.